Safety Study of CALAA-01 to Treat Solid Tumor Cancers
Clinical trial NCT00689065 · TERMINATED
Trial details
- NCT number
- NCT00689065
- Sponsor
- Calando Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2012-09-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.